MY110795A - The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy - Google Patents

The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy

Info

Publication number
MY110795A
MY110795A MYPI94000764A MYPI19940764A MY110795A MY 110795 A MY110795 A MY 110795A MY PI94000764 A MYPI94000764 A MY PI94000764A MY PI19940764 A MYPI19940764 A MY PI19940764A MY 110795 A MY110795 A MY 110795A
Authority
MY
Malaysia
Prior art keywords
therapy
pharmaceutical compositions
sulphate salt
substituted triazole
receptors
Prior art date
Application number
MYPI94000764A
Inventor
Carole Olive
Raymond Baker
Victor G Matassa
Kendal G Pitt
David E Storey
Richard Guiblin Alexander
Leslie J Street
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of MY110795A publication Critical patent/MY110795A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

THE SULPHATE SALT OF N, N-DIMETHYL-2-[5[(1,2,4-TRIAZOL-1-YLMETHYL)-1H-INDOL-3-YL) ETHYLAMINE IS A SELECTIVE AGONIST OF 5-HT1-LIKE RECEPTORS AND IS THEREFORE USEFUL IN THE TREATMENT OF CLINICAL CONDITIONS, IN PARTICULAR MIGRAINE AND ASSOCIATED DISORDERS, FOR WHICH A SELECTIVE AGONIST OF THESE RECEPTORS IS INDICATED.
MYPI94000764A 1993-04-07 1994-03-30 The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy MY110795A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939307306A GB9307306D0 (en) 1993-04-07 1993-04-07 Therapeutic agents

Publications (1)

Publication Number Publication Date
MY110795A true MY110795A (en) 1999-04-30

Family

ID=10733532

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI94000764A MY110795A (en) 1993-04-07 1994-03-30 The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy

Country Status (7)

Country Link
DZ (1) DZ1771A1 (en)
GB (1) GB9307306D0 (en)
HR (1) HRP940225B1 (en)
MY (1) MY110795A (en)
PL (1) PL174489B1 (en)
SI (1) SI9400157A (en)
YU (1) YU17594A (en)

Also Published As

Publication number Publication date
HRP940225B1 (en) 2000-06-30
YU17594A (en) 1997-03-07
GB9307306D0 (en) 1993-06-02
HRP940225A2 (en) 1997-08-31
SI9400157A (en) 1994-12-31
DZ1771A1 (en) 2002-02-17
PL174489B1 (en) 1998-08-31

Similar Documents

Publication Publication Date Title
MY106272A (en) Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants.
MX9707570A (en) USE OF 'alpha'1L AGONISTS IN THE TREATMENT OF INCONTINENCE.
HUP0104696A3 (en) Pharmaceutical composition containing 5ht1 receptor agonists and metoclopramide for the treatment of migraine
AU4337293A (en) The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy
ITRM950480A0 (en) METHOD FOR INCREASING THE RAPIDITY OF BREEDING NEWBORNS THROUGH THE USE OF FEED FOR BREEDING SOWS.
BG104038A (en) Use of specific antagonist of 5ht2 receptors for preparing medicines useful for treating sleep-disordered breathing
WO1993023035A3 (en) Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and parkinson's disease
GB9207396D0 (en) Therapeutic agents
CA2135709A1 (en) Melatonin derivatives for use in treating sleep disorders
MX9707642A (en) Pharmaceutical agents for the treatment of alzheimer's disease.
CA2135710A1 (en) Melatonin derivatives for use in treating desynchronization disorders
NZ303993A (en) Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
PH31258A (en) New use of ropivacaine.
EP0367069A3 (en) Substituted bisazoles, process for their preparation and their use as therapeutic agents
UA29461C2 (en) An agent for treatment of amyloidosis, a method for treatment of amyloidosis
AU6542896A (en) A triazolylmethyl-indole ethylamine bisulfate salt
PT83253A (en) Process for preparing p-acylaminobenzamides
HUP9802314A3 (en) Use of pure 3r-3'r stereoisomer of zeaxanthin for preparation of pharmaceuticals or foodstoffs for treating macular degeneration in humans
AU2137595A (en) Use of arylpiperazine derivatives for the treatment of Parkinson's disease and psychosis
MY108739A (en) Imidazole, triazole and tetrazole derivatives
LT95072A (en) Process for the preparation of 1,2,4-triazole sodium salt
ITMI942673A0 (en) PROCESS FOR THE (CO)POLINERIZATION OF ETHYLENE
AP9600780A0 (en) Process for the preparation of peroxetine hydrochloride anhydrate and its use as therapeutic agent.
MX9709684A (en) Use of vitamin d4 derivatives for treating skin disorders.
YU17594A (en) SULPHATE OF SUBSTITUTED TRIAZOLE AND PHARMACEUTICAL COMPOSITIONS BASED ON THE SAME